These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18367268)

  • 1. LDL size and subclasses in patients with abdominal aortic aneurysm.
    Rizzo M; Krayenbühl PA; Pernice V; Frasheri A; Battista Rini G; Berneis K
    Int J Cardiol; 2009 May; 134(3):406-8. PubMed ID: 18367268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis.
    Berneis K; Rizzo M; Spinas GA; Di Lorenzo G; Di Fede G; Pepe I; Pernice V; Rini GB
    Clin Chim Acta; 2009 Aug; 406(1-2):36-40. PubMed ID: 19433079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
    Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
    Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.
    Rizzo M; Berneis K; Altinova AE; Toruner FB; Akturk M; Ayvaz G; Rini GB; Spinas GA; Arslan M
    Diabet Med; 2008 Dec; 25(12):1406-11. PubMed ID: 19046238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease.
    Rizzo M; Pernice V; Frasheri A; Berneis K
    Atherosclerosis; 2008 Mar; 197(1):237-41. PubMed ID: 17485096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
    Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines and systemic biomarkers are related to the size of abdominal aortic aneurysms.
    Flondell-Sité D; Lindblad B; Kölbel T; Gottsäter A
    Cytokine; 2009 May; 46(2):211-5. PubMed ID: 19251434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].
    Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T
    J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinaemia is associated with the rate of abdominal aortic aneurysm expansion.
    Halazun KJ; Bofkin KA; Asthana S; Evans C; Henderson M; Spark JI
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):391-4; discussion 395-6. PubMed ID: 17164089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haptoglobin phenotypes and plasma haptoglobin levels in patients with abdominal aortic aneurysm.
    Pan JP; Cheng TM; Shih CC; Chiang SC; Chou SC; Mao SJ; Lai ST
    J Vasc Surg; 2011 May; 53(5):1189-94. PubMed ID: 21296538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
    Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E
    Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis.
    Mohty D; Pibarot P; Després JP; Côté C; Arsenault B; Cartier A; Cosnay P; Couture C; Mathieu P
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):187-93. PubMed ID: 17975118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL particle size, fat distribution and insulin resistance in obese children.
    Miyashita M; Okada T; Kuromori Y; Harada K
    Eur J Clin Nutr; 2006 Mar; 60(3):416-20. PubMed ID: 16278685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is increased thrombin activation in patients with abdominal aortic aneurysms dependent on area or volume of aneurysm thrombus mass?
    Kölbel T; Donath T; Strandberg K; Flondell-Sité D; Kühme T; Gottsäter A; Lindblad B
    Angiology; 2010; 61(1):113-8. PubMed ID: 19625264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Karalis DG; Ishisaka DY; Luo D; Ntanios F; Wun CC
    Am J Cardiol; 2007 Aug; 100(3):445-9. PubMed ID: 17659926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the relationship between plasma lipids and abdominal aortic aneurysm: A Mendelian randomization study.
    Weng LC; Roetker NS; Lutsey PL; Alonso A; Guan W; Pankow JS; Folsom AR; Steffen LM; Pankratz N; Tang W
    PLoS One; 2018; 13(4):e0195719. PubMed ID: 29649275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiency.
    Rizzo M; Trepp R; Berneis K; Christ ER
    Growth Horm IGF Res; 2008 Jun; 18(3):264-6. PubMed ID: 18054508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome.
    Rizzo M; Pernice V; Frasheri A; Di Lorenzo G; Rini GB; Spinas GA; Berneis K
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):870-5. PubMed ID: 18771560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.